Skip to main content
Premium Trial:

Request an Annual Quote

Gualberto Ruano

Premium

Genaissance founder Gualberto Ruano has launched a new company, Genomas, which will focus on finding pharmacogenomic links to fitness and eating habits, according to the Hartford Courant. Ruano, 44, resigned from Genaissance on Aug. 31 after being ousted from the chief executive’s slot one year ago. He had served as the firm’s CSO since then. Genomas is self-funded and is based in Ruano’s home.

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.